Human blood platelets lack nitric oxide synthase activity

Platelets

Volumn 26, Issue 6, 2015, Pages 583-588

  Böhmer, Anke ^a   Gambaryan, Stepan ^b,c   Tsikas, Dimitrios ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c SECHENOV INSTITUTE OF EVOLUTIONARY PHYSIOLOGY AND BIOCHEMISTRY   (Russian Federation)

Author keywords

Enzyme activity assays; mass spectrometry; nitric oxide; stable isotopes

Indexed keywords

ADENOSINE DIPHOSPHATE; CITRIC ACID; COLLAGEN; EDETIC ACID; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HEPARIN; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE; NITROGEN 15; THROMBIN; VON WILLEBRAND FACTOR; ANTICOAGULANT AGENT; NITRIC OXIDE SYNTHASE; RECOMBINANT PROTEIN;

ADULT; ANIMAL CELL; ARTICLE; BIOAVAILABILITY; CATALYSIS; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; ERYTHROCYTE; FEMALE; HUMAN; HUMAN CELL; MALE; MASS FRAGMENTOGRAPHY; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; THROMBOCYTE; THROMBOCYTE ACTIVATION; DRUG EFFECTS; ENZYME ACTIVATION; METABOLISM;

ANTICOAGULANTS; BLOOD PLATELETS; ENZYME ACTIVATION; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HEALTHY VOLUNTEERS; HUMANS; MALE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; RECOMBINANT PROTEINS;

EID: 84938600659     PISSN: 09537104     EISSN: 13691635     Source Type: Journal    
DOI: 10.3109/09537104.2014.974024     Document Type: Article

References (37)

1. Daff S. NO synthase: Structures and mechanisms. Nitric Oxide 2010;23:1-11.
2. Tsikas D. A critical review and discussion of analytical methods in the L-arginine/nitric oxide area of basic and clinical research. Anal Biochem 2008;379:139-163.
3. Muruganandam A, Mutus B. Isolation of nitric oxide synthase from human platelets. Biochim Biophys Acta 1994;1200:1-6.
4. Chen LY, Mehta JL. Further evidence of the presence of constitutive and inducible nitric oxide synthase isoforms in human platelets. J Cardiovasc Pharmacol 1996;27:154-158.
5. Kawamato EM, Glezer I, Munhoz CD, Bernardes C, Scavone C, Marcourakis T. Human platelet nitric oxide synthase activity: An optimized method. Braz J Pharmacol Sci 2002;38:305-313.
6. Naseem KM, Riba R. Unresolved roles of platelet nitric oxide synthase. J Thromb Haemost 2008;6:10-19.
7. O'Kane P, Xie L, Liu Z, Queen L, Jackson G, Ji Y, Ferro A. Aspirin acetylates nitric oxide synthase type 3 in platelets thereby increasing its activity. Cardiovasc Res 2009;83:123-130.
8. Momi S, Caracchini R, Falcinelli E, Evagelista S, Gresele P. Stimulation of platelet nitric oxide production by nebivolol prevents thrombosis. Arterioscler Thromb Vasc Biol 2014;34: 820-829.
9. Kleinbongard P, Schulz R, Rassaf T, Lauer T, Dejam A, Jax T, Kumara I, Gharini P, Kabanova S, Ozüyaman B, et al. Red blood cells express a functional endothelial nitric oxide synthase. Blood 2006;107:2943-2951.
10. Cortese-Krott MM, Rodriguez-Mateos A, Sansone R, Kuhnle GGC, Thasian-Sivarajah S, Krenz T, Horn P, Krisp C, Wolters D, Heib C, et al. Human red blood cells at work: Identification and visualization of erythrocytic eNOS activity in health and disease. Blood 2012; 120:4229-4237.
11. Tsikas D. Measurement of nitric oxide synthase activity in vivo and in vitro by gas chromatography-mass spectrometry. Methods Mol Biol 2004;279:81-103.
12. Ozuyaman B, Gudecke A, Kusters S, Kirchhoff E, Scharf RE, Schrader J. Endothelial nitric oxide synthase plays a minor role in inhibition of arterial thrombus formation. Thromb Haemost 2005; 93:1161-1167.
13. Gambaryan S, Kobsar A, Hartmann S, Birschmann I, Kuhlencordt PJ, Müller-Esterl W, Lohmann SM, Walter U. NO-synthase-/ NO-independent regulation of human and murine platelet soluble guanylyl cyclase activity. J Thromb Haemost 2008;6:1376-1384.
14. Tymvios C, Moore C, Jones S, Solomon A, Sanz-Rosa D, Emerson M. Platelet aggregation responses are critically regulated in vivo by endogenous nitric oxide but not by endothelial nitric oxide synthase. Br J Pharmacol 2009;158:1735-1742.
15. Tsikas D, Flentje M, Niemann J, Böhmer A, Stichtenoth DO. Extraplatelet NO and NO+-containing drugs are potent inhibitors of platelet aggregation in humans by cGMP-dependent and cGMPindependent mechanisms. Blood 2012;119:5337-5339.
16. Burkhart JM, Vaudel M, Gambaryan S, Radau S, Walter U, Martens L, Geiger J, Sickmann A, Zahedi RP. The first comprehensive and quantitative analysis of human platelet protein composition allows the comparative analysis of structural and functional pathways. Blood 2012;120:e73-e82.
17. Böhmer A, Gambaryan S, Flentje M, Jordan J, Tsikas D. [ureido-15N]Citrulline UPLC-MS/MS nitric oxide synthase (NOS) activity assay: Development, validation, and applications to assess NOS uncoupling and human platelets NOS activity. J Chromatogr B 2014;965:173-182.
18. Kang ES, Ford K, Grokulsky G, Wang YB, Chiang TM, Acchiardo SR. Normal circulating adult human red blood cells contain inactive NOS proteins. J Lab Clin Med 2000;135:444-451.
19. Böhmer A, Beckmann B, Sandmann J, Tsikas D. Doubts concerning functional endothelial nitric oxide synthase in human erythrocytes. Blood 2012;119:1322-1323.
20. Bode-Böger SM, Böger RH, Galland A, Frölich JC. Differential inhibition of human platelet aggregation and thromboxane A2 formation by L-arginine in vivo and in vitro. Naunyn Schmiedebergs Arch Pharmacol 1998;357:143-150.
21. Zhang G, Xiang B, Dong A, Skoda RC, Daugherty A, Smyth SS, Du X, Li Z. Biphasic roles for soluble guanylyl cyclase (sGC) in platelet activation. Blood 2011;118:3670-3678.
22. Tsikas D, Ikic M, Tewes KS, Raida M, Frölich JC. Inhibition of platelet aggregation by S-nitroso-cysteine via cGMP-independent mechanisms: Evidence of inhibition of thromboxane A2 synthesis in human blood platelets. FEBS Lett 1999;442:162-166.
23. Gordge MP, Hothersall JS, Noronha-Dutra AA. Evidence for a cyclic GMP-independent mechanism in the anti-platelet action of S-nitrosoglutathione. Br J Pharmacol 1998;124:141-148.
24. Villanueva VR, Giret M. Human platelet arginase. Mol Cell Biochem 1980;33:97-100.
25. Barilli A, Visigalli R, Rotoli BM, Bussolati O, Gazzola GC, Parolari A, Dall'Asta V. Radiochemical high-performance liquid chromatography detection of arginine metabolism in human endothelial cells. Anal Biochem 2012;424:156-161.
26. Tsikas D, Sandmann J, Savva A, Luessen P, Böger RH, Gutzki FM, Mayer B, Frölich JC. Assessment of nitric oxide synthase activity in vitro and in vivo by gas chromatography-mass spectrometry. J Chromatogr B 2000;742:143-153.
27. Tsikas D. Simultaneous derivatization and quantification of the nitric oxide metabolites nitrite and nitrate in biological fluids by gas chromatography/mass spectrometry. Anal Chem 2000;72: 4064-4072.
28. Thum T, Tsikas D, Frölich JC, Borlak J. Growth hormone induces eNOS expression and nitric oxide release in a cultured human endothelial cell line. FEBS Lett 2003;555:567-571.
29. Krause P, Wätzig E, Acil H, König S, Unthan-Fechner Kb, Tsikas D, Probst I. Role of carbon monoxide and nitric oxide in adult rat hepatocytes proliferating in vitro: Effects of CAS 1609. Nitric Oxide 2010;23:220-226.
30. Trettin A, Böhmer A, Suchy MT, Probst I, Staerk U, Stichtenoth DO, Frölich JC, Tsikas D. Effects of paracetamol on NOS, COX, and CYP activity and on oxidative stress in healthy male subjects, rat hepatocytes, and recombinant NOS. Oxid Med Cell Longev 2014; 2014:212576.
31. Salvemini D, de Nucci G, Gryglewski RJ, Vane JR. Human neutrophils and mononuclear cells inhibit platelet aggregation by releasing a nitric oxide-like factor. Proc Natl Acad Sci USA 1989; 86:6328-6332.
32. Marescau B, Pintens J, Lowenthal A, Terheggen HG. Excretion of a-keto-d-guanidinovaleric acid and its cyclic form in patients with hyperarginemia. Clin Chim Acta 1979;98:35-38.
33. Tsikas D, Böger RH, Sandmann J, Bode-Böger SM, Frölich JC. Endogenous nitric oxide synthase inhibitors are responsible for the L-arginine paradox. FEBS Lett 2000;478:1-3.
34. Valero N, Espina LM, Anez G, Torres E, Mosquera JA. Short report: Increased levels of serum nitric oxide in patients with dengue. Am J Trop Med Hyg 2002;66:762-764.
35. Mendes-Ribeiro AC, Moss MB, Siqueira MA, Moraes TL, Ellory JC, Mann GE, Brunini TM. Dengue fever activates L-arginine-nitric oxide pathway: An explanation for reduced aggregation of human platelets. Clin Exp Pharmacol Physiol 2008;35:1143-1146.
36. Leithner C, Sinzinger H, Silberbauer K. Prostacyclin as a protective factor for blood vessels. Fortschr Med 1980;98:1845-1849.
37. Fröhlich A, Durner J. The hunt for plant nitric oxide synthase (NOS): Is one really needed? Plant Sci 2011;181:401-404.